Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL887431 | 0.88 | CA12 (0.46) | ALDH1A1CNR2RAB9ANPC1CA12 | |
| SCHEMBL887432 | 0.83 | TACR3 (0.47) | ALDH1A1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8610160 | 0.83 | SMN1; SMN2 (0.55) | SMN1; SMN2ALDH1A1TSHRCYP1A2CYP3A4 | |
| SCHEMBL887430 | 0.82 | ALDH1A1 (0.42) | SMN1; SMN2ALDH1A1TSHRCYP1A2CYP3A4 | |
| SCHEMBL887450 | 0.82 | CTSK (0.53) | SMN1; SMN2TSHRATMMAPT | |
| SCHEMBL3923931 | 0.81 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1TSHRCYP1A2CYP3A4 | |
| SCHEMBL18362239 | 0.74 | SMN1; SMN2 (0.57) | SMN1; SMN2ALDH1A1TSHRATMMAPT | |
| SCHEMBL16245369 | 0.74 | SMN1; SMN2 (0.51) | SMN1; SMN2ALDH1A1TSHRCYP1A2CYP3A4 | |
| SCHEMBL25366914 | 0.73 | TACR3 (0.59) | ALDH1A1TSHRCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL10143994 | 0.72 | RAB9A (0.54) | SMN1; SMN2ALDH1A1RAB9ANPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902207-B2 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20070142639-A1 | Process for production of amines | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142639-A1 | Process for production of amines | SMS, CCNT1, PEAK1 | SMN1; SMN2 2249/4885ALDH1A1 1001/4885TSHR 2162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.